Weakened leukocyte phagocytosis has been found in both Type 1 and Type 2 DM and explains the diminished infecting bacterial clearance during hyperglycemia as observed in mouse models. Phagocytosis was reduced by 50% in the leukocytes in diabetic mice infected by Staphylococcus aureus. The main factor of neutrophil dysfunction is the hyperglycemia, which alters neutrophil chemotaxis, phagocytic action and intracellular killing of the bacteria. Respiratory burst by monocytes from hyperglycemic patients has been affected. Humoral immunity in diabetic patients can be affected as well, which can be shown by a shorter duration of the protective antibodies after tetanus vaccination and lower levels of tetanus antitoxin compared with those in non-diabetic subjects. Alterations in levels of complement fractions can also be found. Hyperglycemia suppresses activation of C3 fraction, which results in changed C3 tertiary structure and impairs the interactions of C3 with the bacterial pathogens [13] . Decreased mobilization of polymorphonuclear leukocytes, chemotaxis, and phagocytic activity may occur during hyperglycemia.
The hyperglycemic environment also blocks the antimicrobial function by inhibiting glucose-6-phosphate dehydrogenase (G6PD), increasing apoptosis of polymorphonuclear leukocytes, and reducing polymorphonuclear leukocyte transmigration through the endothelium. In tissues that do not need insulin for glucose transport, the hyperglycemic environment increases intracellular glucose levels, which are then metabolized, using NADPH as a cofactor. The decrease in the levels of NADPH prevents the regeneration of molecules that play a key role in antioxidant mechanisms of the cell, thereby increasing the susceptibility to oxidative stress [14] . Various studies done worldwide have shown changing patterns in the etiology of UTIs indiabetic patients [15] .
In a cross sectional study conducted in Nepal to assess the spectrum of uropathogens and their antibiotic sensitivity pattern in diabetic patients, the overall culture positivity rate was 34.5%. Escherichia coli was the most frequent organism (64.5%) followed by Klebsiella sps (22.6%). E. coli was highly sensitive to gentamicin and nitrofurantoin among the tested antimicrobials followed by cotrimoxazole, norfloxacin and ciprofloxacin. Least sensitivity rate was observed with ampicillin and cephalexin [16] . In another study conducted in Nepal to determine the prevalence of UTI among diabetic patients, the causative pathogens & their antimicrobial susceptibility pattern the overall prevalence of UTI was found to be 54.76% from the total of 462 diabetic patients. The gram positive isolates and Escherichia coli were found to be sensitive to nitrofurantoin [17] . A prospective study done in India to know the bacteriological and resistance profile of isolates obtained from diabetic patients showed that 18 of 65 (27.7%) had UTI. Twenty six bacterial species were isolated from urine samples. The most frequently isolated species was E.coli followed by K. Pneumoniae [18] .
In a study conducted, for two years in Mysore (Southern India), to determine the prevalence and incidence of urinary tract infection among diabetic patients, about 900 samples were culture positive and 936 isolates were obtained out of 1085 urine samples. Escherichia coli was the major cause for urinary tract infection in both type 1 (34%) and type 2 (32%) diabetic patients, followed by Methicillin resistant Staphylococcus aureus (11.4% and 12.6%) [19] . In a study conducted in Karnataka, India, to determine the frequency of uropathogens and their antibiotic susceptibility in different gender of diabetic patients found that from the total of 44 urine samples 68% of the patients were having asymptomatic bacteriuria. Biochemical characterization revealed prevalent gram negative organisms and E. coli as the predominant solate. Among the antibiotics tested, trimethoprim was found to be effective for empirical treatment of UTI and has covered the majority of urinary pathogens followed by nalidixic acid, Chloramphenicol and kanamycin. Most of the isolates were resistant to oxytetracycline [20] . In a prospective study carried out in Government Medical College Amritsar-India to find out theprevalence of uropathogens in diabetic patients and to study their antibiotic susceptibility pattern bacterial growth was obtained in 118 (43%) cases out of the 270 urine specimens from diabeticpatients. Among these 50.84% (60/118) had asymptomatic bacteruria while symptomatic infection occurred in 49.15 % (58/118) patients. Escherichia coli was the most frequent isolated (41.5%), followed by Klebsiella species (14.4%), Proteus species (10.1%), Enterococci (8.4%), Pseudomonas aeruginosa (6.7%), Staphylococcus species (10.1%) and Candida albicans (8.4%). The isolates showed highest resistance against amoxicillin and ciprofloxacin, moderate resistance against norfloxacin, nitrofurantoin, gentamicin and cefotaxime while resistance against amikacin was low [21] .
In a study done to assess prevalence of urinary tract infection and risk factors among Saudi patients with diabetes, the prevalence of UTI was 25.3 % from the total of 1,000 diabetic patients and 7.2 and 41.1 % in males and females, respectively [22] . In another study conducted in National Center of Diabetes-Baghdad, Iraq on 122 patients with diabetes mellitus to determine the prevalence of uropathogens and their antibiotic susceptibility significant bacteriuria was seen in 60(49.1%) patients. Among the isolates 45 were gram negative bacilli and 15 were gram positive cocci. Among the gram negative bacilli E. coli was the predominant isolate (60%) while Pseudomonas aeruginosa was the least (1.66%). E.coli and Klebsiella pneumoniae showed highest sensitivity to piperacyclin followed by nitrofurantoin. Staphylococcus aureus had highest sensitivity to ciprofloxacin and cefoxitin (75%) and the highest resistance to chloramphenicol (91.7%). Most bacterial isolates exhibited complete resistance to Tetracyclin (100%), only Enterobacter species had sensitivity to Tetracyclin (33.3%) [21] .
A study conducted at Buea and Limbe Regional Hospital Diabetic and Hypertensive Clinic in Cameroon, to investigate the prevalence of asymptomatic bacteriuria and UTIs in clinically diagnosed patients with diabetes and to determine the uropathogens responsible for ASB (asymptomatic bacteriuria) and UTIs as well as their antimicrobial susceptibility pattern, revealed that one hundred and two (81.6%) of the total 125 urine samples had significant bacteriuria. Eight different bacteria were isolated from the study participants: Escherichia coli (48.0%) were the most prevalent, followed by Staphylococcus aureus (19.6%) and Proteus mirabilis (8.9%). Most of the bacterial isolates were highly sensitive to gentamicin (88.6%), imipenem (87.9%), nitrofurantoin (79.5%) and amikacin (88.3%). Some of the bacterial isolates showed 53.3% resistance rate while all the bacterial isolates were highly resistant (96.3%) to amoxicillin [22] .
A cross sectional study conducted at Muhimbili National Hospital-Dar es Salaam, Tanzania to determine the prevalence and risk factors of bacteriuria in diabetic women and antimicrobial resistance pattern of the isolates revealed 13.7% (41/300) significant bacteriuria, of which 13.4% (31/231) and 14.5% (10/69) were asymptomatic and symptomatic bacteriuria, respectively. The isolated pathogens were Escherichia coli (39.0%), Klebsiella pneumoniae (22.0%), coagulase negative Staphylococci (14.65%) and Proteus spp (12.2%). Both Gram positive and negative bacteria showed high rate of resistance towards co-trimoxazole (55.6% and 50.0%, respectively). Gram negative bacteria showed high rate of resistance to ampicillin (62.55%), penicillin (53.1%) and moderate resistance to cefotaxime (18.8%). Most uropathogens were resistant to cotrimoxazole, ampicillin and ciprofloxacin [23] .
A prospective cross sectional study conducted in Gondar University Hospital, Ethiopia, on a total of 422 diabetic patients with asymptomatic UTI (n=387) and symptomatic UTI (n=35), to investigate for urinary tract infection showed 17.8% significant bacteriuria, of which 14.7% were asymptomatic and 51.4% were symptomatic. Out of the total 82 bacterial isolates, E. coli (31.7%), coagulase negative staphylococci (CONs) (22%), Klebsiella spp. (14.6%),Enterococcus spp. (11%) and S. aureus (8.5%) were the commonest bacterial uropathogens inboth groups. All gram negative isolates showed intermediate level of resistance (60-80%) against ampicillin and chloramphenicol. Low level of resistance (<60%) was observed against amoxicillinclavulanic acid, ciprofloxacin, ceftriaxone, gentamicin and trimethoprimsulphamethoxazole. High level of resistance (>80%) was observed against tetracycline. Gram positive bacteria showed low level of resistance (<60%) to all antimicrobials tested except for tetracycline [24] . Therefore, it will be worthwhile to study and understand the common UTI present in diabetic patients of different regions and geographical locations. Such a study will help isolate the organisms which are locally unique to the diabetic patients for infection control and to undertake preventive measures. Multidrug-resistant Acinetobacter baumannii is a rapidly emerging pathogen in the health care setting, where it causes infections that include bacteremia, pneumonia, meningitis, urinary tract infection, and wound infection. The genus Acinetobacter is now defined as including gram-negative coccobacilli, with a DNA G+C content of 39 to 47 mol%, that are strictly aerobic, nonmotile, catalase positive and oxidase negative. Diabetic patients are 10 times more likely to develop Acinetobacter baumannii infections than the rest of the population. Carbapenems are considered one of the very few antibiotics left to treat infections caused by this organism. (25) The aim of this work was to characterise A. baumannii strains isolated from diabetic patients and to investigate whether there is a relationship between certain strains and low-levelcarbapenem resistance.
